Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Multiple Ascending Dose Study of DS-3201b in Subjects With Lymphomas

NCT02732275 is registered in ClinicalTrials.gov with Daiichi Sankyo Co., Ltd. as lead sponsor.

NCT NCT02732275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02732275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Multiple Ascending Dose Study of DS-3201b in Subjects With Lymphomas
Lead sponsor
Daiichi Sankyo Co., Ltd.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 31, 2016
Completion date
December 31, 2027
Enrollment
100 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, malignant, non-hodgkin lymphoma